After the collapse of a potential pharmaceutical megadeal last week, drug companies including Roche Holding Ltd. and GlaxoSmithKline PLC are signing smaller deals to give greater focus to their businesses.

Roche said Monday it is acquiring Genia Technologies, a Mountain View, Calif., company that develops DNA-sequencing technology, for $125 million. The deal will help strengthen the Swiss giant's lead in the broader field of...